Author

B. Szalai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Balla· 1 shared A. Califano· 1 shared A. D. Toth· 1 shared A. Fernandez-Torras· 1 shared A. Inoue· 1 shared A. Pessia· 1 shared C. Karan· 1 shared D. Garger· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Balla

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivApr 27, 2023

Receptor endocytosis orchestrates the spatiotemporal bias of β-arrestin signaling

A. D. Toth, B. Szalai, O. T. Kovacs…·L. Hunyady

The study shows that β-arrestin signaling bias is spatiotemporally determined by ligand dissociation rate and G protein activity at endosomes, not receptor conformation.

DOI 10.1126/scisignal.adi0934

experimental assaystatistical model

𝕏 PostBluesky

Cancer BiologybioRxivDec 21, 2020

A Community Challenge for Pancancer Drug Mechanism of Action Inference from Perturbational Profile Data

E. F. Douglass, R. J. Allaway, B. Szalai…·A. Califano

The paper hosts a DREAM Challenge to evaluate computational models for predicting drug polypharmacology using perturbational profile data from 32 kinase inhibitors.

DOI 10.1016/j.xcrm.2021.100492

humanbulk RNA-seq

𝕏 PostBluesky